Table 1

Characteristics of the patients and their atrial flutter

PatientAge (years)SexAssociated heart disease or arrhythmiaAFL CLaVF/IFW ratioFW polarity
CCWCWCCWCWCCWCW
158MHCM2061964.81.8np
246MAtrial fibrillation1885.0n
361M2882.6n
455MAtrial fibrillation19810.7n
571MAtrial fibrillation1882.8p
671M2439.3n
765MAVRT2001.2e
864F19611.5n
945M2194.7n
1062F2234.6n
1122MAVNRT2061.6p
1243MAtrial fibrillation2283.6n
1334M2133.4e
1439M2173.5n
1553MAtrial fibrillation2050.9p
1645FAVNRT2122.2p
1761M2082116.00.9ee
1846FAVRT, atrial tachycardia2452233.92.1np
1968MCoronary artery disease2216.4n
2048MSick sinus syndrome2371.0p
2169MHCM1983.8e
2267M2212215.41.3np
2362M2414.5n
2446M2182068.01.4np
2578M20711.7e
2645MAtrial septal defect2025.5n
2745M1804.2n
2860F2035.4n
2958F2141.8e
3074M2365.3n
3164MAtrial tachycardia2132199.01.3np
3274FAtrial fibrillation2171.8e
3320M1861847.51.7ne
3457M1973.0e
3583FAVNRT2192254.41.8np
3674MCoronary artery disease2042484.81.7nn
3744MAortic regurgitation2372375.31.4ne
Mean (SD)56 (15)215 (22)215 (16)5.7 (2.5)1.5 (0.4)1-150
  • 1-150 p < 0.00001 compared with aVF/lead I flutter wave amplitude ratio in counterclockwise atrial flutter.

  • AFL, atrial flutter; AVNRT, atrioventricular nodal reentrant tachycardia; AVRT, atrioventricular reciprocating tachycardia; CCW, counterclockwise; CL, cycle length; CW, clockwise; e, equivocal; FW, flutter wave; HCM, hypertrophic cardiomyopathy; n, negative; p, positive.